← All articles

ADHD Lifestyle Clues: Exercise, Sleep, Light, and Diet

A sham-controlled ADHD trial found lifestyle correlations, not proof. What exercise, sleep, evening light, and diet evidence really supports for children.

System Evaluation
Science
75/100
Media
54/100

The trial did not show that lifestyle changes drove improvement

A neurofeedback trial in children with ADHD found that active treatment and sham treatment improved symptoms by similar amounts. That null comparison prompted a reasonable follow-up question: did changes in sleep, activity, food, or evening light help explain why children improved over time?

The answer from the secondary analysis is more limited than the headline-grabbing version. In the 2025 ICAN lifestyle analysis, sleep changes correlated with improvement on a parent-rated inattention measure, but no lifestyle change correlated with the trial's combined parent-and-teacher primary outcome. Exercise and diet signals were non-significant or exploratory. The study identifies candidates worth testing, not the hidden cause of ADHD improvement.

That distinction matters. A parent who improves a child's bedtime routine may also view the child's attention more favorably. A teacher, who sees the child in a different setting, may see no comparable change. Correlation can describe a useful clinical pattern without proving that one variable caused the other.

What ICAN found—and what it could not answer

ICAN included 142 children ages 7 to 10 in a sham-controlled randomized neurofeedback trial. The lifestyle analysis examined changes that occurred naturally in both study groups. It was post-hoc and exploratory, with no protection against the higher false-positive risk created by testing many variables.

Sleep produced the most notable signal. At baseline, poorer sleep on the Children's Sleep Habits Questionnaire correlated with parent-rated inattention (r=0.17, p=0.04), while sleep length correlated with teacher-rated inattention (r=0.20, p=0.03). During the trial, improved sleep quality correlated with improved parent-rated inattention (Spearman rho=0.26, p=0.002). A correlation of 0.26 accounts for roughly 7% of variation in that outcome: statistically detectable, but modest.

The same analysis found correlational consistency among evening LED exposure, delayed melatonin onset, and disrupted sleep. That pattern fits established circadian biology. It does not prove that LEDs caused sleep disruption or that changing lighting would reduce ADHD symptoms in children.

The strongest challenge to a causal reading came from the primary outcome. The combined parent-and-teacher Conners3 score did not significantly correlate with improvement in any lifestyle variable. Teacher ratings also did not reproduce the parent-rated sleep finding. Shared parent-rater bias is therefore a live alternative explanation, not a technical footnote.

Diet and exercise within ICAN were even less conclusive. Food-group variety increased across both arms (d=0.22, p=0.029), while higher protein intake had a marginal association with parent-rated inattention improvement (p=0.06). Changes in exercise time were also marginal and non-significant (p=0.08). Those results should generate better trials, not dietary prescriptions.

Exercise has the best evidence, with an important endpoint caveat

Exercise does not need ICAN's weak naturalistic signal to earn attention. Several independent reviews of randomized trials find that structured exercise improves inhibitory control and executive function in children with ADHD. A 2023 systematic review and meta-analysis found significant improvements in inhibitory function after physical-activity interventions. Inhibitory control—the ability to stop an automatic response and stay on task—relates closely to the impulsive and inattentive problems that define ADHD.

The evidence has since broadened. A 2025 network meta-analysis of 26 randomized controlled trials compared six exercise modalities in children with ADHD and found significant improvements across exercise approaches for inhibitory control, executive function, and gross motor outcomes. A separate RCT-only meta-analysis of aerobic exercise also found executive-function benefits in children and adolescents with ADHD.

More exercise is not automatically better, but prescription details appear to matter. A 2025 network meta-analysis reported that duration, frequency, intensity, and modality each moderated inhibitory-control effects. Earlier pediatric work likewise examined an aerobic exercise dose-response relationship for executive function.

The caveat is practical: most of these trials measure performance on neuropsychological tests such as Stroop-type tasks, continuous-performance tests, or the Wisconsin Card Sorting Test. Those are meaningful outcomes, but they are not the same as a sustained reduction in parent- or teacher-rated inattention. A 2025 exercise review identified the choice between performance tests and behavioral rating scales as a major source of variation across studies.

For families, the reasonable conclusion is still useful. Structured aerobic or multimodal activity belongs in an ADHD care plan as an adjunct, especially when it is feasible and enjoyable enough to continue. It should not be presented as a replacement for assessment, school supports, behavioral treatment, or medication when those are indicated.

Sleep and circadian timing deserve clinical attention

Sleep problems are unusually common in ADHD. A 2025 narrative review of circadian evidence reports delayed sleep-wake cycles in 73% to 78% of people with ADHD and insomnia in up to 82% of pediatric cases. Those figures establish a high burden of co-occurring sleep disruption; they do not settle whether poor sleep worsens ADHD, ADHD disrupts sleep, or both arise partly from shared biology.

There is biological support for taking the question seriously. A 2022 pilot study found different clock-gene expression profiles in children with ADHD versus neurotypical controls. As a pilot biomarker study, it cannot identify treatment targets or justify a supplement dose.

Randomized evidence for chronotherapy comes from a narrower group: adults with ADHD and confirmed delayed sleep phase syndrome. Two trials by van Andel and colleagues found that melatonin-based chronotherapy phase-shifted circadian rhythms and improved ADHD symptoms in that population, including the 2021 randomized clinical trial and its 2022 follow-up sleep trial. Children differ in circadian development, diagnosis, and appropriate melatonin use, so those results cannot become a pediatric protocol by analogy.

Consistent bed and wake times, a calmer and dimmer evening environment, and direct evaluation of persistent insomnia are sensible low-risk steps. Melatonin, however, deserves a clinician's input, particularly for a child. A broader 2022 review of melatonin in psychiatric settings found inconsistent effects on psychiatric symptoms beyond sleep outcomes.

Diet remains a hypothesis in children

The ICAN result on food variety was small, and its protein finding did not reach conventional statistical significance. Neither result tests a dietary intervention. The available review literature is also thin: a 2022 review of dietetic interventions addressed adults, where evidence remained limited and inconsistent.

There is no pediatric randomized trial in this evidence base showing that an overall healthier dietary pattern reduces inattention severity in children with ADHD. Good nutrition still matters for growth, energy, and general health. It simply does not yet justify claims that a particular eating pattern treats childhood ADHD.

What families and trials should do next

ICAN exposes a real design problem: ADHD trials can improve in both arms while unmeasured changes in home routines occur in the background. But its data cannot tell us how much those changes caused the improvement. The next useful study would randomize a pediatric sleep or light-management program, enroll at least 200 children, and pre-register parent and teacher inattention ratings as primary outcomes. Until then, exercise has the clearest evidence; sleep management has a strong rationale but incomplete pediatric trial support; and diet remains an open question.

Comments

No comments yet. Be the first!